Moront M G, Katz N M, Keszler M, Visner M S, Hoy G R, O'Connell J J, Cox C, Wallace R B
Department of Surgery, Georgetown University School of Medicine, Washington, D.C. 20007.
J Thorac Cardiovasc Surg. 1989 May;97(5):706-14.
From February 1985 through June 1987, 50 newborn infants in whom maximal ventilator therapy failed (80% predicted mortality) were treated with extracorporeal membrane oxygenation (ECMO) according to the following inclusion criteria: arterial oxygen tension less than 50 torr (alveolar-arterial oxygen gradient greater than 630 torr) for 2 hours or arterial oxygen tension less than 60 torr (alveolar-arterial oxygen gradient greater than 620 torr) for 8 hours. Criteria for exclusion from ECMO therapy included birth weight less than 2000 gm, gestational age less than 35 weeks, presence of intracranial hemorrhage, presence of other major congenital anomalies including cyanotic heart disease, and high levels of ventilatory support for more than 7 days. Mean birth weight was 3.28 +/- 0.56 kg, mean gestational age was 39.6 +/- 1.7 weeks, and mean age at the start of ECMO was 48.6 +/- 36.9 hours. Meconium aspiration, usually associated with persistent pulmonary hypertension, was the most common cause of pulmonary failure (62%). Mean pre-ECMO arterial oxygen tension during maximal ventilatory and pharmacologic support was 34.5 +/- 14.5 torr. Mean ventilatory support immediately before the institution of ECMO was as follows: peak inspiratory pressure 46.8 +/- 9.9 cm H2O, positive end-expiratory pressure 4.6 +/- 1.6 cm H2O, and intermittent mandatory ventilation rate 101.0 +/- 22.7 breaths/min with all patients receiving an inspired oxygen fraction of 1.0. Lung management to prevent pulmonary atelectasis during ECMO consisted of moderate levels of positive end-expiratory pressure (mean 10.3 +/- 2.6 cm H2O, range 8 to 14 in 94% of patients. Other mean ventilator parameters during ECMO were as follows: peak inspiratory pressure 22.8 +/- 1.6 cm H2O, intermittent mandatory ventilation rate 11.8 +/- 2.9, and inspired oxygen fraction 0.21. The overall long-term patient survival rate was 90%. Mean values for arterial blood gases and ventilator settings immediately after the discontinuation of ECMO were as follows: oxygen tension 78.4 +/- 22.1 torr, pH 7.39 +/- 0.10, carbon dioxide tension 37.4 +/- 10.7 torr, peak inspiratory pressure 25.2 +/- 3.9 cm H2O, positive end-expiratory pressure 5.6 +/- 1.2 cm H2O, and intermittent mandatory ventilation rate 41.3 +/- 12.6 with an inspired oxygen fraction of 0.42 +/- 0.17. Despite slightly higher levels of ventilator support (peak inspiratory pressure 46.8 versus 45.0 cm H2O, not significant) mean pre-ECMO oxygen tension was significantly lower than that reported from the National ECMO Registry (34.5 versus 42.0 torr, p less than 0.01).(ABSTRACT TRUNCATED AT 400 WORDS)
从1985年2月至1987年6月,50例最大程度呼吸机治疗失败(预计死亡率80%)的新生儿,根据以下纳入标准接受体外膜肺氧合(ECMO)治疗:动脉血氧分压低于50托(肺泡-动脉氧梯度大于630托)持续2小时,或动脉血氧分压低于60托(肺泡-动脉氧梯度大于620托)持续8小时。排除ECMO治疗的标准包括出生体重低于2000克、胎龄小于35周、存在颅内出血、存在包括紫绀型心脏病在内的其他主要先天性畸形,以及超过7天的高水平呼吸机支持。平均出生体重为3.28±0.56千克,平均胎龄为39.6±1.7周,开始ECMO治疗时的平均年龄为48.6±36.9小时。胎粪吸入通常与持续性肺动脉高压相关,是呼吸衰竭最常见的原因(62%)。在最大程度呼吸机和药物支持期间,ECMO前平均动脉血氧分压为34.5±14.5托。在开始ECMO之前,平均呼吸机支持情况如下:吸气峰压46.8±9.9厘米水柱,呼气末正压4.6±1.6厘米水柱,间歇指令通气频率101.0±22.7次/分钟,所有患者吸入氧分数为1.0。在ECMO期间,预防肺不张的肺部管理包括适度水平的呼气末正压(平均10.3±2.6厘米水柱,94%的患者范围为8至14厘米水柱)。ECMO期间的其他平均呼吸机参数如下:吸气峰压22.8±1.6厘米水柱,间歇指令通气频率11.8±2.9次/分钟,吸入氧分数0.21。总体长期患者生存率为90%。ECMO停止后立即测得的动脉血气和呼吸机设置的平均值如下:氧分压78.4±22.1托,pH值7.39±0.10,二氧化碳分压37.4±10.7托,吸气峰压25.2±3.9厘米水柱,呼气末正压5.6±1.2厘米水柱,间歇指令通气频率41.3±12.6次/分钟,吸入氧分数0.42±0.17。尽管呼吸机支持水平略高(吸气峰压46.8对45.0厘米水柱,无显著差异),但ECMO前平均氧分压显著低于国家ECMO登记处报告的水平(34.5对42.0托,p<0.01)。(摘要截短至400字)